Accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease - prospective longitudinal study in a multi-ethnic population: the eGFR-C study

niversity of Birmingham (UK)0 个研究点目标入组 1,320 人2013年10月8日

概览

注册库

who.int

开始日期

2013年10月8日

结束日期

2020年6月30日

最后更新

去年

研究类型

Observational

性别

All

发起方

niversity of Birmingham (UK)

•1\. Male and female, aged 18 years or over
•2\. Patients with stage 3 CKD (GFR 30\-59 mL/min/1\.73 m2\) as defined internationally, diagnosed using Modification of Diet in Renal Disease/Chronic Kidney Disease Epidemiology Collaboration (MDRD/CKD EPI) eGFR (at least two consecutive test results in this range at least 90 days apart, with the most recent test in the last 12 months)
•3\. Written informed consent

•1\. History of untoward reactions to iodinated contrast media or allergy to topical iodine
•2\. Episode of acute kidney injury in previous 6 months (as defined by the Acute Kidney Injury Network criteria)
•3\. Amputation of whole or part limb
•4\. Pregnant or breastfeeding
•5\. Known alcohol or drug abuse
•6\. Any clinical condition with an expected survival of less than study duration
•7\. Inability to comply with study schedule and follow\-up
•8\. Inability to provide informed consent e.g. due to cognitive impairment